Evidence map›Paper›PMID 42763607›Full record

ArticleMediastinum (Hong Kong, China)2026

Invasive thymoma with rapid response to cisplatin, doxorubicin and cyclophosphamide (PAC) chemotherapy, after an early postoperative recurrence-a case report.

Chika Harada, Kentaro Kitano, Hiroki Umezawa, Chiyoko Kono, Hiroki Tanaka, Rie Ohtomo

Abstract readCase Reports
In one paragraph

Article in Mediastinum (Hong Kong, China), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chika HaradaDepartment of Thoracic Surgery, JR Tokyo General Hospital, Tokyo, Japan.
Kentaro KitanoDepartment of Thoracic Surgery, JR Tokyo General Hospital, Tokyo, Japan.
Hiroki UmezawaDepartment of Respiratory Medicine, JR Tokyo General Hospital, Tokyo, Japan.
Chiyoko KonoDepartment of Respiratory Medicine, JR Tokyo General Hospital, Tokyo, Japan.
Hiroki TanakaDepartment of Pathology, JR Tokyo General Hospital, Tokyo, Japan.
Rie OhtomoDepartment of Pathology, JR Tokyo General Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Thymomas generally exhibit indolent growth and local progression, with extrathoracic metastases being rare. Recurrence typically occurs months or years after surgical resection. We herein present a rare case of thymoma exhibiting rapid postoperative recurrence and abdominal lymph node metastasis, which showed a dramatic response to chemotherapy. Case Description: A 66-year-old female was referred to our hospital for breast cancer treatment. A preoperative computed tomography (CT) scan coincidentally revealed a 7.5 cm anterior mediastinal tumor, suspected to be invading the pericardium and left lung. Extended thymothymectomy with partial resection of the left lung and pericardium was performed. Intraoperatively, no pleural dissemination was observed, and pleural effusion cytology was negative for malignant cells. The pathology was Type AB thymoma, Masaoka stage III [tumor, node, metastasis (TNM) 8th edition: pT3N0M0, Stage IIIA; TNM 9th edition: pT2N0M0, Stage II], with microscopically positive (R1) margins; thus, postoperative radiotherapy was planned. On postoperative day (POD) 18, she presented with dyspnea and massive left pleural effusion; after repeated thoracocentesis, the effusion recurred, and the patient was readmitted for continuous drainage. On POD 43, a CT scan showed a massive lesion along the left thoracic wall adjacent to the pericardium, with multiple small nodes in the left lung and two enlarged left gastric lymph nodes. A CT-guided needle biopsy of the thoracic wall performed on POD 47 confirmed recurrent thymoma. The patient received chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC), with biochemical evidence of rapid tumor lysis that did not meet formal tumor lysis syndrome criteria. Chest X-ray on day 3 of chemotherapy showed near-complete resolution of the thoracic lesions, and a complete response, including normalization of the abdominal lymph nodes, was achieved after four courses of PAC. Serial follow-up imaging has shown no evidence of recurrence for at least 18 months. Conclusions: This case illustrates the diagnostic complexity of thymoma, including atypical radiological and pathological features together with an unusually aggressive early recurrence. Incomplete resection can lead to early recurrence and progression, and clinicians must remain vigilant for such atypical courses. The tumor nonetheless proved highly sensitive to chemotherapy, underscoring the importance of prompt systemic treatment intervention when recurrence occurs.

Indexed as

abdominal lymph node metastasiscase reportrapid progressionThymoma

Identifiers

PMID42763607
PMCPMC13589322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.